Steven Cha
Chief Tech/Sci/R&D Officer at PROCESSA PHARMACEUTICALS, INC.
Steven Cha active positions
Companies | Position | Start | End |
---|---|---|---|
PROCESSA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 29/04/2024 | - |
Career history of Steven Cha
Former positions of Steven Cha
Companies | Position | Start | End |
---|---|---|---|
IMUGENE LIMITED | Chief Tech/Sci/R&D Officer | 31/01/2022 | 31/05/2022 |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Chief Tech/Sci/R&D Officer | - | - |
Training of Steven Cha
University of California San Diego | Undergraduate Degree |
Tufts University School of Medicine | Doctorate Degree |
Statistics
International
United States | 5 |
Australia | 2 |
Operational
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
IMUGENE LIMITED | Health Technology |
PROCESSA PHARMACEUTICALS, INC. | Health Technology |
Private companies | 1 |
---|---|
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Health Technology |
- Stock Market
- Insiders
- Steven Cha
- Experience